| The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer Ç Şakalar, K İzgi, B İskender, S Sezen, H Aksu, M Çakır, B Kurt, A Turan, ... Tumor Biology 37, 4467-4477, 2016 | 94 | 2016 |
| Differential expression of programmed death 1 (PD-1) on various immune cells and its role in human leprosy M Tarique, H Naz, M Suhail, A Turan, C Saini, N Muhammad, H Shankar, ... Frontiers in immunology 14, 1138145, 2023 | 24 | 2023 |
| Engineering pancreatic islets with a novel form of thrombomodulin protein to overcome early graft loss triggered by instant blood-mediated inflammatory reaction A Turan, L Zhang, M Tarique, V Ulker, FN Arguc, D Badal, ES Yolcu, ... American Journal of Transplantation 23 (5), 619-628, 2023 | 6 | 2023 |
| Membrane‐coated nanoparticles for direct recognition by T cells F Li, F Li, R Urie, E Bealer, RO Ruiz, E Saito, A Turan, E Yolcu, H Shirwan, ... Biotechnology and Bioengineering 120 (3), 767-777, 2023 | 4 | 2023 |
| A modified surgical procedure using minimally invasive ileocolic vein perfusion in a mouse intrahepatic islet transplant model L Zhang, A Turan, H Shirwan, ES Yolcu STAR protocols 3 (2), 101416, 2022 | 4 | 2022 |
| A study of Staphylococcus aureus nasal carriage, antibacterial resistance and virulence factor encoding genes in a tertiary care hospital, Kayseri, Turkey M Oguzkaya-Artan, C Artan, Z Baykan, C Sakalar, A Turan, H Aksu Nigerian Journal of Clinical Practice 18 (5), 594-600, 2015 | 4 | 2015 |
| Engineering donor lymphocytes with Fas ligand protein effectively prevents acute graft-versus-host disease P Shrestha, A Turan, L Batra, AE Gulen, Z Sun, H Tan, N Askenasy, ... Blood Advances 7 (10), 2181-2195, 2023 | 3 | 2023 |
| Engineering Pancreatic Islets to Transiently Codisplay on Their Surface Thrombomodulin and CD47 Immunomodulatory Proteins as a Means of Mitigating Instant Blood-Mediated … A Turan, M Tarique, L Zhang, S Kazmi, V Ulker, MG Tedla, D Badal, ... The Journal of Immunology 212 (12), 1971-1980, 2024 | 2 | 2024 |
| 201.1: Co-engineering pancreatic islets with novel forms of thrombomodulin and CD47 as an effective means of mitigating instant blood-mediated inflammatory reaction A Turan, M Tarique, S Kazmi, L Zhang, V Ulker, ES Yolcu, H Shirwan Transplantation 107 (10S2), 36, 2023 | 1 | 2023 |
| 226.8: Targeting apoptotic pathway to eliminate Teff cells as an effective approach to prevent acute GVHD in a humanized mouse model. E Yolcu, P Shrestha, A Turan, H Shirwan Transplantation 108 (9S), 2024 | | 2024 |
| 322.4: Engineering pancreatic islet grafts with innate immune modulators to mitigate instant blood-mediated inflammatory reaction. M Tarique, A Turan, S Kazmi, L Zhang, V Ulker, D Badal, ES Yolcu, ... Transplantation 108 (9S), 2024 | | 2024 |
| Thrombomodulin and CD47 proteins displayed on the surface of pancreatic islets improve engraftment following intraportal transplantation M Tarique, A Turan, S Kazmi, L Zhang, V Vulker, D Badal, M Tedla, ... The Journal of Immunology 212 (1_Supplement), 0313_5680-0313_5680, 2024 | | 2024 |
| Engineering islet surface with a novel form of thrombomodulin protein to mitigate instant blood-mediated inflammatory reaction following intraportal transplantation A Turan, L Zhang, M Tarique, V Ulker, F Arguc, E Yolcu, H Shirwan The Journal of Immunology 210 (Supplement_1), 173.35-173.35, 2023 | | 2023 |
| 214.3: Thrombomodulin Protein Transiently Tethered To Surface of Islets Enhance Engraftment in an Intraportal Transplantation Model by Inhibiting Peri-transplant Inflammatory … A Turan, L Zhang, M Tarique, V Ulker, AE Gulen, ES Yolcu, H Shirwan Transplantation 106 (9S), S35, 2022 | | 2022 |
| Ficoll-Based Isolation Alters the Immunogenicity of Islets That Leads to Enhanced Rejection in Allogeneic Hosts. L Zhang, A Turan, M Tarique, V Ulker, E Yolcu, H Shirwan AMERICAN JOURNAL OF TRANSPLANTATION 22, 1008-1008, 2022 | | 2022 |
| Pancreatic Islets Engineered with Thrombomodulin Show Enhanced Engraftment in an Intraportal Transplantation Model by Mitigating Instant Blood-Mediated Inflammatory Reactions. A Turan, L Zhang, M Tarique, V Ulker, E Yolcu, H Shirwan AMERICAN JOURNAL OF TRANSPLANTATION 22, 411-411, 2022 | | 2022 |
| A novel peptide-specific monoclonal antibody with a potential use for immunotherapy recognizes AMHR2 expressed by ovarian cancer cells C Sakalar, H Aksu, A Turan, S Kaya, C Mustafa, K Busra, S Sedat, C Halit European Journal of Cancer 61, S212, 2016 | | 2016 |